Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome
Open Access
- 15 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (2), 767-775
- https://doi.org/10.1182/blood-2007-04-085670
Abstract
Children with Down syndrome (DS) display macrocytosis, thrombocytosis, and a 500-fold increased risk of developing megakaryocytic leukemia; however, the specific effects of trisomy 21 on hematopoiesis remain poorly defined. To study this question, we analyzed blood cell development in the Ts65Dn mouse model of DS. Ts65Dn mice are trisomic for 104 orthologs of Hsa21 genes and are the most widely used mouse model for DS. We discovered that Ts65Dn mice display persistent macrocytosis and develop a myeloproliferative disease (MPD) characterized by profound thrombocytosis, megakaryocyte hyperplasia, dysplastic megakaryocyte morphology, and myelofibrosis. In addition, these animals bear distorted hematopoietic stem and myeloid progenitor cell compartments compared with euploid control littermates. Of the 104 trisomic genes in Ts65Dn mice, Aml1/Runx1 attracts considerable attention as a candidate oncogene in DS–acute megakaryoblastic leukemia (DS-AMKL). To determine whether trisomy for Aml1/Runx1 is essential for MPD, we restored disomy at the Aml1/Runx1 locus in the Ts65Dn strain. Surprisingly, trisomy for Aml1/Runx1 is not required for megakaryocyte hyperplasia and myelofibrosis, suggesting that trisomy for one or more of the remaining genes can promote this disease. Our studies demonstrate the potential of DS mouse models to improve our understanding of chromosome 21 gene dosage effects in human hematologic malignancies.Keywords
This publication has 40 references indexed in Scilit:
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopeniaProceedings of the National Academy of Sciences of the United States of America, 2006
- The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiationProceedings of the National Academy of Sciences, 2006
- Intrinsic Abnormalities of Lymphocyte Counts in Children with Down SyndromeThe Journal of Pediatrics, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesisBlood, 2003
- Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21Blood, 2003
- Peripheral blood cell counts in infants with Down's syndromeClinical Genetics, 1996
- Hematologic abnormalities in children with down syndromeAmerican Journal of Medical Genetics, 1993